BenevolentAI
therapy area and business model rationale competitive commercial scientific commercial clinical development data core therapeutic areas clinical development development out license at phase i or phase scientific strategy out license prior to phase i non core therapeutic areas collaborations non commercial collaborations | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
21 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Presentation
October 2022
therapy area and business model rationale competitive commercial scientific commercial clinical development data core therapeutic areas clinical development development out license at phase i or phase scientific strategy out license prior to phase i non core therapeutic areas collaborations non commercial collaborations | BenevolentAI
Related slides by other companies
Freeman Capital Management
Activist
May 2023
flawed clinical development strategy | Freeman Capital Management
Petco
Investor Day
March 2022
investing drive growth priority projected annual spend investment areas core invest vet pet care centers supply chain digital innovate committed to achieving well above hurdle rate returns rural vital care | Petco
Cytek
Investor Day
June 2022
today focus areas | Cytek
RayzeBio
IPO
September 2023
stepwise approach for clinical development in | RayzeBio
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io